Cancer therapeutics is an area of constant innovation. Historically, cancer treatments have been a very invasive and detrimental process to the body. Now, there are numerous new techniques now available for those with cancer that are not as invasive and detrimental to the body as a whole. The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. The mainstay of systemic therapy for solid and hematological malignancies in the 20th century was chemotherapy. This approach has drawbacks including toxicity to normal tissue, drug resistance and lack of efficacy. The demand for more effective and tolerable treatments has led to the development of novel therapeutic agents that specifically target the malignant cells. Increasingly, immunological treatments are taking center stage. These reports offer market sizing, estimates, forecasts and trend information for cancer treatments.